$2.25 +0.03 (1.35%)

Mangoceuticals, Inc. Common Stock (MGRX)

Mangoceuticals, Inc. (MGRX) is a biopharmaceutical company focused on the development and commercialization of innovative nutraceutical and pharmaceutical products. The company leverages its expertise in formulation science to create health and wellness products that address various medical and nutritional needs. Mangoceuticals aims to integrate natural ingredients with advanced biomedical research to bring effective solutions to consumers.

🚫 Mangoceuticals, Inc. Common Stock does not pay dividends

Company News

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division
GlobeNewswire Inc. • N/A • April 25, 2025

Mangoceuticals, a health and wellness company, has acquired the intellectual property and assets of Smokeless Technology Corp., a Canadian-based pouch innovation company. This acquisition will allow Mangoceuticals to expand into the growing oral pouch delivery market. The company has also appointed Tim Corkum, a former executive at Philip Morris, to lead its high-growth pouch division.

Azz Inc. COO acquires $21.2k in company stock By Investing.com - Investing.com Australia
Investing.com • Brando Bricchi • July 12, 2024

Mangoceuticals, a health and wellness company, has appointed Dr. Douglas Christianson as the new Director of Medical Research and Product Innovation. Dr. Christianson will lead the company's product development efforts, particularly in areas like erectile dysfunction, hair growth, weight loss, and hormone replacement therapies.

Spotting Penny Stocks Before They Explode, Top Tips
PennyStocks • D. Marie • May 22, 2024

Here's some tips for finding penny stocks before they shoot up in value The post Spotting Penny Stocks Before They Explode, Top Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
Benzinga • Avi Kapoor • March 25, 2024

Shares of Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) rose sharply in today’s pre-market trading following fourth-quarter results. Salarius Pharmaceuticals posted a net loss of $0.9 million, or 22 cents per share for the fourth quarter, narrower than the year-ago loss of $6.4 million, or $2.83 per share, according to data from Benzinga Pro. Salarius Pharmaceuticals shares jumped 31.4% to $0.8149 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Next.e.GO N.V. (NASDAQ: EGOX) shares rose 85.8% to $0.0730 in pre-market trading after falling around 22% on Friday. MicroAlgo Inc. (NASDAQ: MLGO) rose 56.7% to $6.30 in pre-market trading after declining around 5% on Friday. Forge Global Holdings, Inc. (NYSE: FRGE) shares gained 22.8% to $2.86 in pre-market trading after gaining 13% on Friday. Canopy Growth Corporation (NASDAQ: CGC) gained 19.5% to $9.17 in pre-market trading. The German government approved legislation which legalizes the possession and cultivation of cannabis beginning April 1. Flora Growth Corp. (NASDAQ: FLGC) shares rose 17.7% to $1.86 in pre-market trading after surging around 34% on Friday. Cazoo Group ...

Sientra, Tesla and GM shares rise and EvGo and Planet Labs slump, along with more stocks on the move
MarketWatch • MarketWatch • June 9, 2023

Shares of Tesla and GM, along with DocuSign and Braze are moving higher on Friday. Planet Labs is headed the other way.